Obscure recurrent gastrointestinal bleeding: a revealed mystery?

Area of Science:

• Gastroenterology
• Endoscopy
• Diagnostic Imaging

Background:

• Capsule endoscopy (CE) is the primary diagnostic tool for obscure gastrointestinal bleeding (OGIB) after negative upper and lower gastrointestinal (GI) endoscopy.
• A significant proportion of patients undergoing CE for OGIB have bleeding sources located in the stomach or colon, not just the small bowel.
• Identifying missed lesions from conventional endoscopy is crucial for effective patient management in OGIB.

Purpose of the Study:

• To determine the incidence of bleeding lesions in the upper or lower GI tract that were missed by prior gastroscopy and colonoscopy.
• To evaluate the utility of CE in detecting these missed lesions in patients with obscure GI bleeding.
• To assess the indications for repeating comprehensive endoscopic workup in patients with obscure bleeding before CE.

Main Methods:

• Prospective review of data from 637 patients who underwent CE for obscure bleeding at a tertiary center.
• All patients had previously negative gastroscopy and colonoscopy examinations.
• Analysis focused on lesions identified by CE located outside the small bowel.

Main Results:

• CE identified a cause of bleeding in the stomach in 21.7% (138/637) and in the colon in 6.4% (41/637) of patients with prior negative endoscopies.
• Lesions outside the small bowel were detected in 8.5% (54/637) of patients.
• In patients with upper/lower GI lesions, CE also frequently identified small-bowel abnormalities, and all patients received appropriate therapy.

Conclusions:

• Approximately 28% of patients with obscure bleeding have upper or lower GI lesions missed by conventional endoscopy.
• Capsule endoscopy plays a vital role in uncovering these missed lesions, improving diagnostic yield in OGIB.
• CE can guide further endoscopic interventions or surgical management for non-small bowel lesions.